1. Home
  2. APLT vs RDNW Comparison

APLT vs RDNW Comparison

Compare APLT & RDNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • RDNW
  • Stock Information
  • Founded
  • APLT 2016
  • RDNW 2013
  • Country
  • APLT United States
  • RDNW United States
  • Employees
  • APLT N/A
  • RDNW 1964
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • RDNW EDP Services
  • Sector
  • APLT Health Care
  • RDNW Technology
  • Exchange
  • APLT Nasdaq
  • RDNW Nasdaq
  • Market Cap
  • APLT 178.6M
  • RDNW 202.9M
  • IPO Year
  • APLT 2019
  • RDNW N/A
  • Fundamental
  • Price
  • APLT $0.26
  • RDNW $5.27
  • Analyst Decision
  • APLT Buy
  • RDNW Hold
  • Analyst Count
  • APLT 5
  • RDNW 1
  • Target Price
  • APLT $4.13
  • RDNW $4.00
  • AVG Volume (30 Days)
  • APLT 24.7M
  • RDNW 57.6K
  • Earning Date
  • APLT 11-13-2025
  • RDNW 11-04-2025
  • Dividend Yield
  • APLT N/A
  • RDNW N/A
  • EPS Growth
  • APLT N/A
  • RDNW N/A
  • EPS
  • APLT N/A
  • RDNW N/A
  • Revenue
  • APLT $1,000,000.00
  • RDNW $1,095,200,000.00
  • Revenue This Year
  • APLT N/A
  • RDNW N/A
  • Revenue Next Year
  • APLT $5,935.35
  • RDNW $7.73
  • P/E Ratio
  • APLT N/A
  • RDNW N/A
  • Revenue Growth
  • APLT N/A
  • RDNW N/A
  • 52 Week Low
  • APLT $0.22
  • RDNW $1.46
  • 52 Week High
  • APLT $10.48
  • RDNW $7.06
  • Technical
  • Relative Strength Index (RSI)
  • APLT 27.74
  • RDNW N/A
  • Support Level
  • APLT $0.26
  • RDNW N/A
  • Resistance Level
  • APLT $0.40
  • RDNW N/A
  • Average True Range (ATR)
  • APLT 0.12
  • RDNW 0.00
  • MACD
  • APLT -0.07
  • RDNW 0.00
  • Stochastic Oscillator
  • APLT 4.83
  • RDNW 0.00

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About RDNW RideNow Group Inc.

RideNow Group Inc is a USA-based online retailer that allows consumers and dealers both to Buy-Sell-Trade-Finance pre-owned motorcycles in an efficient, fast, transparent, and engaging experience.

Share on Social Networks: